⚡ Stock Ideas This Week: BioCardia (+56%), Nutanix (+18%) + More
Here is your latest instalment of Cashu’s ‘In A Nutshell’ market signals series.
Twice a week, we bring you the biggest and most crucial stock signals we've picked up in the Cashu App (Apple, Android), ensuring you're always in the know and ahead of the market.
⚡Stock Ideas For You
🟢 BioCardia Inc (BCDA) | +55.73% since alert
🎯New Price Target Signal
3 analysts think BCDA stock price will increase by 926.16%. The current median analyst target is $25.50 compared to a current stock price of $2.48. The lowest analysts target is $25.25 and the highest analyst target is $26.25.
📙What does BCDA do?
BioCardia, Inc., a clinical-stage biotherapeutic company based in Sunnyvale, California with 30 employees, is developing two bone marrow-derived cell therapy platforms for treating cardiac and respiratory conditions. Their therapies, targeting HFrEF, CMI, and ARDS, utilize the Helix system for minimally invasive delivery directly into the heart muscle.
🟢 Nutanix Inc - Class A (NTNX) | +18.22% since alert
💡New Patent Signal
NTNX filed a patent for "technique to store and rapidly hydrate high frequency snapshots on object storage" on Thu, July 27, 2023. The patent was officially published on Thu, August 15, 2024
📙What does NTNX do?
Nutanix, Inc., headquartered in San Jose, California, provides a cloud platform using web-scale engineering and consumer-grade design, integrating consistent cloud operating models across various environments. The company, which went public in 2016, employs 6,450 people and offers subscription-based hybrid cloud infrastructure solutions.
🟢 Grupo Aeroportuario Del Pacifico SAB de CV (PAC) | +13.58% since alert
🎯New Price Target Signal
17 analysts think PAC stock price will increase by 8.19%. The current median analyst target is $169.78 compared to a current stock price of $156.93. The lowest analysts target is $165.81 and the highest analyst target is $179.42.
📙What does PAC do?
Grupo Aeroportuario del Pacifico, S.A.B. de C.V. is a holding company. The Company holds concessions to operate, maintain and develop approximately 10 international airports in the Pacific and Central regions of Mexico, and an international airport in Jamaica.
🟢 STRATA Skin Sciences Inc (SSKN) | +12.99% since alert
🎯New Price Target Signal
3 analysts think SSKN stock price will increase by 410.80%. The current median analyst target is $16.32 compared to a current stock price of $3.19. The lowest analysts target is $16.16 and the highest analyst target is $16.80.
📙What does SSKN do?
STRATA Skin Sciences, Inc., a medical technology company based in Horsham, Pennsylvania, specializes in developing and marketing dermatology and plastic surgery products like the XTRAC and Pharos lasers for treating skin conditions such as psoriasis and vitiligo. The company, which employs 114 full-time staff and went public in 2005, operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment.
Never miss price altering alerts again. Download Cashu on iOS or Android for FREE now.